Cargando…

A Comparative Assessment of Approvals and Discontinuations of Systemic Antibiotics and Other Therapeutic Areas

Since 1980, the US Congress has passed legislation providing several incentives to encourage the development and regulatory approval of new drugs, particularly antibiotics. We assessed long-term trends and characteristics of approvals and discontinuations of all new molecular entities, new therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodriguez-Monguio, Rosa, Seoane-Vazquez, Enrique, Powers, John H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298669/ https://www.ncbi.nlm.nih.gov/pubmed/37372877 http://dx.doi.org/10.3390/healthcare11121759

Ejemplares similares

Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals
por: Hao, Jing, et al.
Publicado: (2015)

Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes
por: Kwon, Christina S., et al.
Publicado: (2018)

Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication
por: Balkhi, Bander, et al.
Publicado: (2018)

Innovation and competition in advanced therapy medicinal products
por: Seoane‐Vazquez, Enrique, et al.
Publicado: (2019)

Predictors of shortages of opioid analgesics in the US: Are the characteristics of the drug company the missing puzzle piece?
por: Rodriguez-Monguio, Rosa, et al.
Publicado: (2021)

Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies
por: Nguyen, Diane, et al.
Publicado: (2013)

Drug utilization and cost in a Medicaid population: A simulation study of community vs. mail order pharmacy
por: Valluri, Satish, et al.
Publicado: (2007)

Incentives for orphan drug research and development in the United States
por: Seoane-Vazquez, Enrique, et al.
Publicado: (2008)

Disentangling the Cost of Orphan Drugs Marketed in the United States
por: Althobaiti, Hana, et al.
Publicado: (2023)

Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients’ health needs?
por: Rodriguez-Monguio, R., et al.
Publicado: (2017)

Evidence at time of regulatory approval and cost of new antibiotics in 2016-19: cohort study of FDA approved drugs
por: Mitra-Majumdar, Mayookha, et al.
Publicado: (2022)

PIN58 The U.S. International Trade of Medical Products in the COVID-19 Era
por: Preciado, S.M., et al.
Publicado: (2021)

A Patient‐Centric Model for Discontinuation of a Single‐Sourced Approved Drug
por: Caplan, Arthur, et al.
Publicado: (2019)

Financing of U.S. Biomedical Research and New Drug Approvals across Therapeutic Areas
por: Dorsey, E. Ray, et al.
Publicado: (2009)

Needle EMG induced muscle bleeding complication after guideline approved discontinuation of anticoagulation
por: Bartl, Michael, et al.
Publicado: (2021)

A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories
por: Falagas, Matthew E., et al.
Publicado: (2006)

Composed endotypes to guide antibiotic discontinuation in sepsis
por: Bermejo-Martin, Jesus F., et al.
Publicado: (2019)

New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics
por: Ebata, Satoshi, et al.
Publicado: (2022)

Re-evaluation of FDA-approved antibiotics with increased diagnostic accuracy for assessment of antimicrobial resistance
por: Heithoff, Douglas M., et al.
Publicado: (2023)

Healthcare cost of type 1 diabetes mellitus in new-onset children in a hospital compared to an outpatient setting
por: Jasinski, Christopher F, et al.
Publicado: (2013)

A Manual of Materia Medica and Therapeutics; Including the Preparation of the British Pharmacopœia and Many Other Approved Medicines
Publicado: (1865)

Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
por: Cohen, Isaac V., et al.
Publicado: (2017)

Immunological Aspects of Approved MS Therapeutics
por: Rommer, Paulus S., et al.
Publicado: (2019)

First Therapeutic Approval for Eosinophilic Esophagitis
por: Al-Horani, Rami A., et al.
Publicado: (2022)

Clinical Pharmacokinetics of Approved RNA Therapeutics
por: Jo, Seong Jun, et al.
Publicado: (2023)

Comparing cancer drug approval systems in the United States and Japan
por: Kaneda, Yudai, et al.
Publicado: (2023)

Discontinuous Dynamical Systems
por: Luo, Albert C J
Publicado: (2012)

Discontinuous Čebyšev systems
por: Zielke, Roland
Publicado: (1979)

Hidden dynamics: the mathematics of switches, decisions and other discontinuous behaviour
por: Jeffrey, Mike R
Publicado: (2018)

Chemistry, structure and function of approved oligonucleotide therapeutics
por: Egli, Martin, et al.
Publicado: (2023)

Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers
por: Vollmer, Brandi, et al.
Publicado: (2018)

Publisher Correction: Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
por: Cohen, Isaac V., et al.
Publicado: (2017)

Assessing the flow to low-income urban areas of conservation and environmental funds approved by California’s Proposition 84
por: Davies, Ian P., et al.
Publicado: (2019)

Melting Point Distribution Analysis of Globally Approved and Discontinued Drugs: A Research for Improving the Chance of Success of Drug Design and Discovery
por: Mao, Fei, et al.
Publicado: (2016)

Premature Discontinuation of Prospective Clinical Studies Approved by a Research Ethics Committee – A Comparison of Randomised and Non-Randomised Studies
por: Blümle, Anette, et al.
Publicado: (2016)

In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine
por: Luykx, Jurjen J., et al.
Publicado: (2020)

Principles of Discontinuous Dynamical Systems
por: Akhmet, Marat
Publicado: (2010)

System dynamics with interaction discontinuity
por: Luo, Albert C J, et al.
Publicado: (2015)

EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA
por: ROY, ARCHANA, et al.
Publicado: (2021)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k9950tdf86e0ci0aj044jfp8b9